The FDA lifted the clinical hold on Aardvark's Investigational New Drug application for ARD-101 on October 22, 2026. The company plans to request an FDA meeting to align on a new Phase 3 trial design ...
Youth, a program by the Greater Chambersburg Chamber Foundation, is now accepting applications from current ninth-grade ...
The Minnesota Office of Cannabis Management has opened a new application period for $10.9 million in grants supporting ...
TAIPEI, Oct. 23, 2026 /PRNewswire/ -- As artificial intelligence (AI) technology continues to advance rapidly, AI is ...
On-device AI chip startup Mobilint was named lead researcher for South Korea’s $606M K-On-Device program, tasked with ...
Samsung Members app reveals a redesigned banner hinting that the One UI 9.5 beta program could launch sooner than expected.
Being marketed to 6,500+ Corexa Health Pharmacy Network of independent pharmaciesTo be launched first at Corexa ...
The Light & Heavy Passenger Rail Conference, presented by Railway Age and Railway Track & Structures on Nov. 4-5, is designed ...
Anthropic Guest Investigators program opens a 14-day application window for academic principal investigators to collaborate ...
Initial and updated cohort data from ongoing Phase 1/2 study of highly selective non-brain-penetrant PARP1 inhibitor EIK1003 continue to support ...
Employers can now apply for up to $1,000 per participating employee under the Workforce Retention and Retraining Program, a ...
Pathos AI announced multi-year strategic collaborations with Bristol Myers Squibb and Tempus AI, Inc. to build a specialized, curated dataset and agentic AI capabilities for Alzheimer?s disease and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results